{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:22:01Z","timestamp":1740108121345,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologe"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00347-020-01265-5","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T18:18:32Z","timestamp":1606241912000},"page":"1128-1133","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapie eines Sekund\u00e4rglaukoms nach intravitrealer Anti-VEGF-Therapie mit dem XEN\u00ae-Gel-Stent und Mitomycin\u00a0C","Treatment of secondary glaucoma following intravitreal anti-VEGF therapy with the XEN\u00ae gel stent and mitomycin\u00a0C"],"prefix":"10.1007","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5222-6445","authenticated-orcid":false,"given":"Mohammad Seleman","family":"Bedar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Kellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"issue":"3","key":"1265_CR1","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/bjophthalmol-2016-308668","volume":"101","author":"T Wecker","year":"2017","unstructured":"Wecker\u00a0T, Ehlken\u00a0C, B\u00fchler\u00a0A et al (2017) Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV. Br J Ophthalmol 101(3):353\u2013359. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-308668","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"1265_CR2","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00417-012-1981-0","volume":"250","author":"N Mathalone","year":"2012","unstructured":"Mathalone\u00a0N, Arodi-Golan\u00a0A, Sar\u00a0S et al (2012) Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 250(10):1435\u20131440. https:\/\/doi.org\/10.1007\/s00417-012-1981-0","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"2","key":"1265_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ajo.2014.04.029","volume":"158","author":"NA Yannuzzi","year":"2014","unstructured":"Yannuzzi\u00a0NA, Patel\u00a0SN, Bhavsar\u00a0KV et al (2014) Predictors of sustained intraocular pressure elevation in eyes receiving intravitreal anti-vascular endothelial growth factor therapy. Am J Ophthalmol 158(2):319\u2013327.e2. https:\/\/doi.org\/10.1016\/j.ajo.2014.04.029","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"1265_CR4","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1016\/j.jfo.2018.07.002","volume":"41","author":"I Leleu","year":"2018","unstructured":"Leleu\u00a0I, Penaud\u00a0B, Blumen-Ohana\u00a0E et al (2018) Late and sustained intraocular pressure elevation related to intravitreal anti-VEGF injections: cases requiring filtering surgery. J\u00a0Fr Ophtalmol 41(8):e329\u2013e340. https:\/\/doi.org\/10.1016\/j.jfo.2018.07.002","journal-title":"J Fr Ophtalmol"},{"issue":"11","key":"1265_CR5","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s00417-017-3782-y","volume":"255","author":"S Vo Kim","year":"2017","unstructured":"Vo Kim\u00a0S, Fajnkuchen\u00a0F, Sarda\u00a0V et al (2017) Sustained intraocular pressure elevation in eyes treated with intravitreal injections of anti-vascular endothelial growth factor for diabetic macular edema in a\u00a0real-life setting. Graefes Arch Clin Exp Ophthalmol 255(11):2165\u20132171. https:\/\/doi.org\/10.1007\/s00417-017-3782-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"1265_CR6","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s00417-019-04362-7","volume":"257","author":"QN Cui","year":"2019","unstructured":"Cui\u00a0QN, Gray\u00a0IN, Yu\u00a0Y et\u00a0al (2019) Repeated intravitreal injections of antivascular endothelial growth factors and risk of intraocular pressure medication use. Graefes Arch Clin Exp Ophthalmol 257(9):1931\u20131939. https:\/\/doi.org\/10.1007\/s00417-019-04362-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"1265_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/IAE.0b013e318261a6f7","volume":"33","author":"QV Hoang","year":"2013","unstructured":"Hoang\u00a0QV, Tsuang\u00a0AJ, Gelman\u00a0R et al (2013) Clinical predictors of sustained intraocular pressure elevation due to intravitreal anti-vascular endothelial growth factor therapy. Retina 33(1):179\u2013187. https:\/\/doi.org\/10.1097\/IAE.0b013e318261a6f7","journal-title":"Retina"},{"issue":"1","key":"1265_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.18240\/ijo.2020.01.12","volume":"13","author":"A Sternfeld","year":"2020","unstructured":"Sternfeld\u00a0A, Ehrlich\u00a0R, Weinberger\u00a0D et al (2020) Effect of different lens status on intraocular pressure elevation in patients treated with anti-vascular endothelial growth factor injections. Int J Ophthalmol 13(1):79\u201384. https:\/\/doi.org\/10.18240\/ijo.2020.01.12","journal-title":"Int J Ophthalmol"},{"issue":"5","key":"1265_CR9","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1097\/IAE.0000000000000520","volume":"35","author":"VS Dedania","year":"2015","unstructured":"Dedania\u00a0VS, Bakri\u00a0SJ (2015) Sustained elevation of intraocular pressure after intravitreal anti-VEGF agents: What is the evidence? Retina 35(5):841\u2013858. https:\/\/doi.org\/10.1097\/IAE.0000000000000520","journal-title":"Retina"},{"issue":"2","key":"1265_CR10","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/j.jfo.2018.12.002","volume":"42","author":"J Buffault","year":"2019","unstructured":"Buffault\u00a0J, Baudouin\u00a0C, Labb\u00e9\u00a0A (2019) XEN\u00ae\u00a0Gel Stent for management of chronic open angle glaucoma: a review of the literature. J\u00a0Fr Ophtalmol 42(2):e37\u2013e46. https:\/\/doi.org\/10.1016\/j.jfo.2018.12.002","journal-title":"J Fr Ophtalmol"},{"issue":"5","key":"1265_CR11","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s00417-019-04251-z","volume":"257","author":"H Reitsamer","year":"2019","unstructured":"Reitsamer\u00a0H, Sng\u00a0C, Vera\u00a0V et al (2019) Two-year results of a\u00a0multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 257(5):983\u2013996. https:\/\/doi.org\/10.1007\/s00417-019-04251-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"1265_CR12","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s00417-018-3899-7","volume":"256","author":"RA Widder","year":"2018","unstructured":"Widder\u00a0RA, Dietlein\u00a0TS, Dinslage\u00a0S et al (2018) The XEN45 Gel Stent as a\u00a0minimally invasive procedure in glaucoma surgery: success rates, risk profile, and rates of re-surgery after 261 surgeries. Graefes Arch Clin Exp Ophthalmol 256(4):765\u2013771. https:\/\/doi.org\/10.1007\/s00417-018-3899-7","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"1265_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ajo.2010.04.011","volume":"150","author":"P Abraham","year":"2010","unstructured":"Abraham\u00a0P, Yue\u00a0H, Wilson\u00a0L (2010) Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 2. Am J Ophthalmol 150(3):315\u2013324.e1. https:\/\/doi.org\/10.1016\/j.ajo.2010.04.011","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1265_CR14","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3928\/15428877-20120618-01","volume":"43","author":"SE Skalicky","year":"2012","unstructured":"Skalicky\u00a0SE, Ho\u00a0I, Agar\u00a0A et al (2012) Glaucoma filtration surgery following sustained elevation of intraocular pressure secondary to intravitreal anti-VEGF injections. Ophthalmic Surg Lasers Imaging 43(4):328\u2013334. https:\/\/doi.org\/10.3928\/15428877-20120618-01","journal-title":"Ophthalmic Surg Lasers Imaging"},{"issue":"8","key":"1265_CR15","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00417-019-04341-y","volume":"257","author":"MT Marcos Parra","year":"2019","unstructured":"Marcos Parra\u00a0MT, Salinas L\u00f3pez\u00a0JA, L\u00f3pez Grau\u00a0NS et al (2019) XEN implant device versus trabeculectomy, either alone or in combination with phacoemulsification, in open-angle glaucoma patients. Graefes Arch Clin Exp Ophthalmol 257(8):1741\u20131750. https:\/\/doi.org\/10.1007\/s00417-019-04341-y","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"1265_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40123-019-0161-2","volume":"8","author":"HB Dick","year":"2019","unstructured":"Dick\u00a0HB, Schultz\u00a0T, Gerste\u00a0RD (2019) Miniaturization in glaucoma monitoring and treatment: a review of new technologies that require a\u00a0minimal surgical approach. Ophthalmol Ther 8(1):19\u201330. https:\/\/doi.org\/10.1007\/s40123-019-0161-2","journal-title":"Ophthalmol Ther"},{"key":"1265_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-019-01271-w","author":"A Olgun","year":"2020","unstructured":"Olgun\u00a0A, Aktas\u00a0Z, Ucgul\u00a0AY (2020) XEN gel implant versus gonioscopy-assisted transluminal trabeculotomy for the treatment of open-angle glaucoma. Int Ophthalmol. https:\/\/doi.org\/10.1007\/s10792-019-01271-w","journal-title":"Int Ophthalmol"},{"issue":"2","key":"1265_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/ICU.0b013e32834ff1e7","volume":"23","author":"H Saheb","year":"2012","unstructured":"Saheb\u00a0H, Ahmed\u00a0IIK (2012) Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol 23(2):96\u2013104. https:\/\/doi.org\/10.1097\/ICU.0b013e32834ff1e7","journal-title":"Curr Opin Ophthalmol"},{"issue":"2","key":"1265_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/ICU.0000000000000457","volume":"29","author":"E Yook","year":"2018","unstructured":"Yook\u00a0E, Vinod\u00a0K, Panarelli\u00a0JF (2018) Complications of micro-invasive glaucoma surgery. Curr Opin Ophthalmol 29(2):147\u2013154. https:\/\/doi.org\/10.1097\/ICU.0000000000000457","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"1265_CR20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000365253","volume":"52","author":"Y Ichiyama","year":"2014","unstructured":"Ichiyama\u00a0Y, Sawada\u00a0T, Kakinoki\u00a0M et al (2014) Anterior chamber paracentesis might prevent sustained intraocular pressure elevation after intravitreal injections of ranibizumab for age-related macular degeneration. Ophthalmic Res 52(4):234\u2013238. https:\/\/doi.org\/10.1159\/000365253","journal-title":"Ophthalmic Res"},{"issue":"14","key":"1265_CR21","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"DM Brown","year":"2006","unstructured":"Brown\u00a0DM, Kaiser\u00a0PK, Michels\u00a0M et al (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N\u00a0Engl J Med 355(14):1432\u20131444. https:\/\/doi.org\/10.1056\/NEJMoa062655","journal-title":"N Engl J Med"}],"container-title":["Der Ophthalmologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01265-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-020-01265-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-020-01265-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,4]],"date-time":"2021-11-04T15:04:13Z","timestamp":1636038253000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-020-01265-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["1265"],"URL":"https:\/\/doi.org\/10.1007\/s00347-020-01265-5","relation":{},"ISSN":["0941-293X","1433-0423"],"issn-type":[{"type":"print","value":"0941-293X"},{"type":"electronic","value":"1433-0423"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"assertion":[{"value":"13 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.S.\u00a0Bedar und U.\u00a0Kellner geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Alle beschriebenen Untersuchungen am Menschen wurden im Einklang mit nationalem Recht sowie gem\u00e4\u00df der Deklaration von Helsinki von 1975 (in der aktuellen, \u00fcberarbeiteten Fassung) durchgef\u00fchrt. Von allen beteiligten Patienten liegt eine Einverst\u00e4ndniserkl\u00e4rung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}